Prospects of antibodies targeting CD47 or CD24 in the treatment of glioblastoma
Author:
Affiliation:
1. The Third Xiangya Hospital of Central South University Changsha China
2. Chinese PLA General Hospital and PLA Medical CollegeChinese PLA Institute of Neurosurgery Beijing China
3. Zhuzhou Central Hospital Zhuzhou China
Funder
National Natural Science Foundation of China
Publisher
Wiley
Subject
Pharmacology (medical),Physiology (medical),Psychiatry and Mental health,Pharmacology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/cns.13714
Reference157 articles.
1. Structural and functional features of central nervous system lymphatic vessels
2. Modulation of T-cell function by gliomas
3. Flow cytometry and in vitro analysis of human glioma–associated macrophages
4. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human glioma;Dunn GP;Cancer Immunity,2007
5. The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recent advances in biomimetic strategies for the immunotherapy of glioblastoma;Biomaterials;2024-12
2. Modulating macrophage-mediated programmed cell removal: An attractive strategy for cancer therapy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09
3. From mechanism to therapy: the journey of CD24 in cancer;Frontiers in Immunology;2024-05-31
4. Glioma-associated macrophages: unraveling their dual role in the microenvironment and therapeutic implications;Current Medicine;2024-04-07
5. The efferocytosis process in aging: Supporting evidence, mechanisms, and therapeutic prospects for age-related diseases;Journal of Advanced Research;2024-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3